Can Pharmaceutical Care Interventions Improve Type 2 Diabetes Management?

Enugu State, Nigeria – Cost-utility analysis was developed to help decision makers compare the values of alternative interventions. With the increasing demand for better management of type 2 diabetes, attention has been focused on the potential benefits of pharmaceutical care (PC) to improve patients’ health outcomes.

In the study, ‘‘Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Type 2 Diabetes Patients,’’ published in Value in Health Regional Issue, researchers found that the pharmaceutical care intervention was very cost-effective.

The PC intervention led to incremental cost and effect of NGN 10,623 ($69) and 0.12 QALY gained respectively with an associated ICUR of NGN 88,525 ($571)/QALY gained. The extra cost paid for extra QALY is rational as it saves future expenditures and improves the quality of life of the patients.

Lead author, Maxwell Adibe, PhD from the University of Nigeria, states, “The results are of interest to health economists and health service researchers, in particular.  These results should be considered by decision makers when allocating resources to diabetes care.” The full study, “Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Type 2 Diabetes Patients,” is published in Value in Health Regional Issues.


Value in Health Regional Issues  (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Posted in Value in Health Regional Issues Tagged with: , , ,